Amedisys shareholders filed the lawsuit in a Baton Rouge federal court in 2010 against the company and some of its former top executives. In their lawsuit, the plaintiffs claim Amedisys’ former management “expressly or implicitly approved” a scheme to increase the company’s home health visits volume to inflate Medicare bonus payments.
The home health provider’s insurers will pay about $15 million of the settlement, while Amedisys will cover the remainder, the report states. Amedisys projects a pre-tax charge of $28.8 million in the second quarter due to the settlement.
In 2014, Amedisys paid a $150 million settlement for allegedly increasing Medicare home visits to boost payments.
More articles on legal and regulatory issues:
Pain Management Group to pay $312k to resolve false billing allegations
Patient stabs University of Nebraska Medical Center employee
Healthcare executive gets nearly 10 years in prison for $56.5M fraud scheme
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
